Sabra Healthcare REIT Inc (SBRA) Fair Value & Analysis
Real Estate · US · Market cap $4.6B · ISIN US78573L1061
What is Sabra Healthcare REIT Inc really worth?
Sabra Healthcare REIT Inc
SBRA · US
A solid business, but trading 100% above our fair value of $10.49.
Strengths
Risks
For context
Fair value as of: Aug 23, 2026
From 16 valuation models · updated 13 days ago
Share price +1.3% over the past month.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The price sits above even our optimistic bull case ($13.11). The favourable scenario is already priced in.
- Solid but not exceptional quality (62/100) and above fair value, neither a clear bargain nor a standout compounder.
- As a real-estate business, asset- and dividend-based methods carry more weight here than a standard DCF.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 23, 2026.
How to read this chart
60‑month range $7.93 – $22.39 · fair‑value band $8.85 – $13.11 · the $20.93 price screens above the $10.49 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 23, 2026.
Analysis
Sabra Healthcare REIT Inc (SBRA) currently trades at $20.93, while our model-based Fair Value estimate is $10.49, implying the stock looks roughly 99.5% overvalued today. The Quality Score stands at 62/100 (solid quality), in the Real Estate sector. Bull case: the DCF Models group reads highest at a median of $24.97 per share, and 5 of the 16 models we run sit above the $20.93 price. Bear case: the Asset-Based group reads lowest at $7.50, and 11 of the 16 models stay below the price. Evidence for this calculation is high.
Over the trailing twelve months, Sabra Healthcare REIT Inc generated revenue of $816M at a net margin of 19.2%. Revenue grew 21.7% year over year. It earns a return on equity of 5.7%. Net debt stands at $2.5B. Fundamentals as of Aug 23, 2026
Our scenario range runs from $8.85 (bear case) to $13.11 (bull case); at $20.93, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 2% below its 52-week high and 28% above its 52-week low, currently above its 200-day average. For context, the median of 10 Real Estate peers we cover trades at −47% fair-value upside, at −50%, SBRA screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.
All 16 models by family
Widest divergence: DCF Models ($24.97) versus Asset-Based ($7.50). Highest evidence: Residual Income (76).
Notify me when SBRA reaches fair value
Put SBRA on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Free, no payment details. Unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 23, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 60 · Market factors (momentum, volatility) 69
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. Sabra Health Care REIT, Inc. is incorporated on May 10th, 2010 and is based in Tustin, United States.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Sabra Healthcare REIT Inc reported revenue of $775M in FY2025 versus $570M in FY2021, a compound +8.0%/yr. Reported net income was $156M in FY2025.
of which total revenue +13.4 % · buybacks/dilution −14.5 %
Annual growth per factor. These are factors, not summands: multiplied they give the EPS growth rate, added they do not quite. Start and end points are 3-year averages (details on hover).
SBRA screens 100% overvalued. Compare with Welltower Inc →
Earlier news
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.
- Sabra Health Care REIT (SBRA) Could Be 5% Below Fair Value Following AFFO And Outlook Reaffirmation
- Sabra Health Care REIT Inc (SBRA) (Q2 2026) Earnings Call Highlights: Strong Senior Housing ...
- Sabra Healthcare (SBRA) Tops Q2 FFO and Revenue Estimates
- Sabra Reports Second Quarter 2026 Results; Reiterates 2026 Guidance
Peer Group
REIT - Healthcare Facilities · 25 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs REIT - Healthcare Facilities median · lower = cheaper
Strength profile in five axes (Snowflake)
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more REIT - Healthcare Facilities stocks, each showing price versus our Fair Value estimate (as of Aug 23, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Welltower Inc WELL | $238.07 | $41.85 | −82% |
| Ventas, Inc VTR | $89.01 | $17.91 | −80% |
| Omega Healthcare Investors, Inc OHI | $45.99 | $29.19 | −37% |
| Healthpeak Properties, Inc DOC | $21.40 | $6.95 | −68% |
| American Healthcare REIT, Inc AHR | $56.19 | $10.94 | −81% |
| CareTrust REIT, Inc CTRE | $39.61 | $22.79 | −42% |
| Healthcare Realty Trust Incorporated HR | $19.39 | $20.60 | +6% |
| Aedifica NV AED | €66.55 | €34.97 | −47% |
| Chartwell Retirement Residences CSHUN | C$21.17 | C$3.49 | −84% |
| National Health Investors, Inc NHI | $72.27 | $64.82 | −10% |
Compare Sabra Healthcare REIT Inc with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Real Estate stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Sabra Healthcare REIT Inc (SBRA) overvalued or undervalued?
What is the fair value of SBRA?
What is the quality score of SBRA?
What is the revenue of Sabra Healthcare REIT Inc (SBRA)?
What is the net profit margin of SBRA?
Does Sabra Healthcare REIT Inc pay a dividend?
Watch Sabra Healthcare REIT Inc in the live analysis
One click puts Sabra Healthcare REIT Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.